2176-14-9 Usage
Uses
Used in Pharmaceutical Industry:
3,5-DIMETHOXY-4-HYDROXYPHENETHYLAMINE HYDROCHLORIDE is used as a therapeutic agent for the treatment of depression and anxiety disorders due to its agonistic effect on serotonin 5-HT2 receptors, which may help alleviate symptoms associated with these conditions.
Used in Research Settings:
3,5-DIMETHOXY-4-HYDROXYPHENETHYLAMINE HYDROCHLORIDE is used as a research tool to study the effects of serotonin receptor activation on neural systems and behavior, providing valuable insights into the underlying mechanisms of mood regulation and cognitive function.
Used in Substance Abuse Treatment:
3,5-DIMETHOXY-4-HYDROXYPHENETHYLAMINE HYDROCHLORIDE is being investigated for its potential role in the treatment of substance abuse disorders, as its interaction with serotonin receptors may offer a novel approach to managing addiction and withdrawal symptoms.
Check Digit Verification of cas no
The CAS Registry Mumber 2176-14-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,7 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2176-14:
(6*2)+(5*1)+(4*7)+(3*6)+(2*1)+(1*4)=69
69 % 10 = 9
So 2176-14-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO3.ClH/c1-13-8-5-7(3-4-11)6-9(14-2)10(8)12;/h5-6,12H,3-4,11H2,1-2H3;1H
2176-14-9Relevant articles and documents
Biosynthesis. Part 24. Speculative Incorporation Experiments with 1-Benzylisoquinolines and a Logical Approach via C6-C2 and C6-C3 Precursors to the Biosynthesis of Hasubanonine and Protostephanine
Battersby, Alan R.,Jones, Raymond C. F.,Kazlauskas, Rymantas,Thornber, Craig W.,Ruchirawat, Somsak,Staunton, James
, p. 2016 - 2029 (2007/10/02)
Many possible 1-benzyltetrahydroisoquinolines have been examined as possible advanced precursors of the alkaloids hasubanonine (1) and protostephanine (2) in Stephania japonica plants, but none was incorporated significantly.Administration of various precursor molecules having only one aromatic ring, such as tyrosine, has demonstrated that both alkaloids are derived from two different C6-C2 biogenetic units.The subsequent failure of further 1-benzyltetrahydroisoquinolines and bisphenethylamines to be incorporated suggested the intermediacy of either (a) modified 1-benzylisoquinolines or (b) trioxygenated C6-C2 building blocks.Precursors designed to examine the first possibility, such as 1-benzyl-3,4-dihydroisoquinolines or 1-benzyl-1-carboxytetrahydroisoquinolines, were not incorporated into (1) and (2) whereas two 3',4',5'-trioxygenated 2-phenylethylamines were incorporated.These findings allow further delineation of the requirements for later precursors of the alkaloids (1) and (2).
